Literature DB >> 25674280

Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.

Wenyi Luo1, Sarah W Lindley1, Peter H Lindley2, Gregory A Krempl3, Raja R Seethala4, Kar-Ming Fung1.   

Abstract

Mammary gland analog secretary carcinoma (MASC) of salivary gland is typically a tumor of low histologic grade and behaves as a low-grade malignancy with relatively benign course. This tumor shares histologic features, immunohistochemical profile, and a highly specific genetic translocation, ETV6-NTRK3, with secretory carcinoma of breast. Histologically, it is often mistaken as acinic cell carcinoma, adenocarcinoma not otherwise specified, and other primary salivary gland tumors. Here we report a case of MASC with high-grade transformation and cervical lymph node metastases confirmed with ETV6-NTRK3 translocation arising in the hard palate of a 41 year-old adult. Interestingly, the metastatic carcinoma has lower grade than the original tumor which strongly support malignant transformation of the original tumor. Most commonly, MASC arises from the parotid gland and less often in minor salivary glands. Metastasis is relatively uncommon and high-grade histology has only been reported in four cases with three of them arising from the parotid gland and the location of the fourth one has not been reported. This is the first case with high grade histology that arise from minor salivary gland and it emphasizes the importance of molecular screening of salivary gland tumor with high-grade histology for ETV6-NTRK3 translocation. In our literature of 115 cases that includes the current case, MASC occurred predominantly in adult with only a few cases under 18 years of age and a male to female ratio of 1.2:1. Parotid gland is more commonly affected but there is also significant occurrence in minor salivary glands. Except for the cases with high grade histology, the overall prognosis is good.

Entities:  

Keywords:  Analog secretary carcinoma; high grade; immunohistochemistry; salivary gland

Mesh:

Substances:

Year:  2014        PMID: 25674280      PMCID: PMC4313953     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion.

Authors:  André Fehr; Thomas Löning; Göran Stenman
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.

Authors:  Christopher C Griffith; Edward B Stelow; Anjali Saqi; Walid E Khalbuss; Frank Schneider; Simion I Chiosea; Raja R Seethala
Journal:  Cancer Cytopathol       Date:  2012-12-05       Impact factor: 5.284

3.  Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Authors:  Andre Pinto; Vania Nosé; Claudia Rojas; Yao-Shan Fan; Carmen Gomez-Fernandez
Journal:  Mod Pathol       Date:  2013-06-28       Impact factor: 7.842

4.  Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Authors:  Ashton Connor; Bayardo Perez-Ordoñez; Mary Shago; Alena Skálová; Ilan Weinreb
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

5.  Mammary analog secretory carcinoma of salivary gland: cytologic diagnosis and differential diagnosis of an unreported entity.

Authors:  Latha Pisharodi
Journal:  Diagn Cytopathol       Date:  2012-04-30       Impact factor: 1.582

6.  Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.

Authors:  David P Horowitz; Charu S Sharma; Eileen Connolly; Daniela Gidea-Addeo; Israel Deutsch
Journal:  Breast       Date:  2012-04-10       Impact factor: 4.380

Review 7.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 8.  Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands.

Authors:  Justin A Bishop
Journal:  Head Neck Pathol       Date:  2013-03-05

9.  Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma.

Authors:  Akeesha A Shah; Bruce M Wenig; Robin D LeGallo; Stacey E Mills; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2014-07-31

Review 10.  "Dedifferentiation" and high-grade transformation in salivary gland carcinomas.

Authors:  Toshitaka Nagao
Journal:  Head Neck Pathol       Date:  2013-07-03
View more
  11 in total

Review 1.  Newly described salivary gland tumors.

Authors:  Alena Skalova; Michal Michal; Roderick Hw Simpson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  Salivary gland hybrid tumour revisited: could they represent high-grade transformation in a low-grade neoplasm?

Authors:  Henrik Hellquist; Alena Skalova; Bahram Azadeh
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

3.  Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.

Authors:  Bin Xu; Ruth Aryeequaye; Lu Wang; Nora Katabi
Journal:  Head Neck Pathol       Date:  2017-10-04

4.  A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.

Authors:  S Reynolds; M Shaheen; G Olson; M Barry; J Wu; T Bocklage
Journal:  Head Neck Pathol       Date:  2016-04-13

Review 5.  Secretory Carcinoma of the Oral Cavity: A Retrospective Case Series with Review of Literature.

Authors:  Shankar Venkat; Sarah Fitzpatrick; Peter A Drew; Indraneel Bhattacharyya; Donald M Cohen; Mohammed N Islam
Journal:  Head Neck Pathol       Date:  2021-03-03

6.  High-grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?

Authors:  Niels J Rupp; Constanze Nemes; Elisabeth J Rushing; Gerhard F Huber; Sandra N Freiberger
Journal:  Head Neck Pathol       Date:  2021-02-05

7.  Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.

Authors:  Yuichiro Hamamoto; Hiroshi Harada; Masaharu Kohara; Keiichiro Honma; Shin-Ichi Nakatsuka; Eiichi Morii
Journal:  Med Mol Morphol       Date:  2020-06-01       Impact factor: 2.070

Review 8.  Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review.

Authors:  Henrik Hellquist; Alena Skálová; Leon Barnes; Antonio Cardesa; Lester D R Thompson; Asterios Triantafyllou; Michelle D Williams; Kenneth O Devaney; Douglas R Gnepp; Justin A Bishop; Bruce M Wenig; Carlos Suárez; Juan P Rodrigo; Andrés Coca-Pelaz; Primož Strojan; Jatin P Shah; Marc Hamoir; Patrick J Bradley; Carl E Silver; Pieter J Slootweg; Vincent Vander Poorten; Afshin Teymoortash; Jesus E Medina; K Thomas Robbins; Karen T Pitman; Luiz P Kowalski; Remco de Bree; William M Mendenhall; Jean Anderson Eloy; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2016-02-19       Impact factor: 3.845

Review 9.  Secretory carcinoma: the eastern Canadian experience and literature review.

Authors:  David Forner; Martin Bullock; Daniel Manders; Timothy Wallace; Christopher J Chin; Liane B Johnson; Matthew H Rigby; Jonathan R Trites; Mark S Taylor; Robert D Hart
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-11-16

10.  Diagnosis and treatment of secretory carcinoma arising from the oral minor salivary gland: Two case reports.

Authors:  Masaru Ogawa; Satoshi Yokoo; Takahiro Yamaguchi; Keisuke Suzuki; Mai Seki-Soda; Takahiro Shimizu; Jun Kurihara; Takaya Makiguchi
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.